|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
153,922,000 |
Market
Cap: |
6.15(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$39.95 - $39.95 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
541,223 |
Total Sell Value |
$0 |
$0 |
$0 |
$15,166,753 |
Total People Sold |
0 |
0 |
0 |
4 |
Total Sell Transactions |
0 |
0 |
0 |
28 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Westby Keith |
SVP & COO |
|
2021-12-13 |
4 |
S |
$14.74 |
$66,603 |
D/D |
(4,517) |
120,074 |
|
- |
|
Carroll David Francis |
SVP, CFO and Treasurer |
|
2021-12-13 |
4 |
S |
$14.74 |
$86,051 |
D/D |
(5,836) |
97,365 |
|
- |
|
Sblendorio Glenn |
Chief Executive Officer |
|
2021-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,950 |
329,292 |
|
- |
|
Westby Keith |
SVP & COO |
|
2021-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
124,591 |
|
- |
|
Carroll David Francis |
SVP, CFO and Treasurer |
|
2021-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
103,201 |
|
- |
|
Carroll David Francis |
SVP, CFO and Treasurer |
|
2021-12-10 |
4 |
S |
$14.53 |
$52,517 |
D/D |
(3,614) |
90,701 |
|
- |
|
Westby Keith |
SVP & COO |
|
2021-12-10 |
4 |
S |
$14.53 |
$52,517 |
D/D |
(3,614) |
112,091 |
|
- |
|
Carroll David Francis |
SVP, CFO and Treasurer |
|
2021-12-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
94,315 |
|
- |
|
Westby Keith |
SVP & COO |
|
2021-12-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
115,705 |
|
- |
|
Sblendorio Glenn |
Chief Executive Officer |
|
2021-12-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,750 |
306,342 |
|
- |
|
Dugel Pravin |
President |
|
2021-11-11 |
4 |
OE |
$1.65 |
$7,000 |
D/D |
4,237 |
45,936 |
|
- |
|
Simms Christopher Paul |
Senior Vice President, CCOOffi |
|
2021-08-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,000 |
|
- |
|
Blumenkranz Mark S. |
Director |
|
2021-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
Westby Keith |
SVP & COO |
|
2021-01-04 |
4 |
S |
$6.85 |
$81,344 |
D/D |
(11,875) |
86,466 |
|
- |
|
Carroll David Francis |
SVP, CFO and Treasurer |
|
2021-01-04 |
4 |
S |
$6.85 |
$81,344 |
D/D |
(11,875) |
80,165 |
|
- |
|
Westby Keith |
SVP & COO |
|
2020-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,500 |
98,341 |
|
- |
|
Carroll David Francis |
SVP, CFO and Treasurer |
|
2020-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,500 |
92,040 |
|
- |
|
Westby Keith |
SVP & COO |
|
2020-12-14 |
4 |
S |
$7.16 |
$32,413 |
D/D |
(4,527) |
65,841 |
|
- |
|
Guyer David R |
Executive Chairman |
|
2020-12-14 |
4 |
S |
$7.16 |
$66,373 |
D/D |
(9,270) |
70,113 |
|
- |
|
Westby Keith |
SVP & COO |
|
2020-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
70,368 |
|
- |
|
Guyer David R |
Executive Chairman |
|
2020-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,200 |
79,383 |
|
- |
|
Carroll David Francis |
SVP, CFO and Treasurer |
|
2020-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
59,540 |
|
- |
|
Sblendorio Glenn |
President and CEO |
|
2020-12-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,950 |
273,773 |
|
- |
|
Westby Keith |
SVP & COO |
|
2020-12-10 |
4 |
S |
$6.96 |
$25,585 |
D/D |
(3,676) |
57,868 |
|
- |
|
Guyer David R |
Executive Chairman |
|
2020-12-10 |
4 |
S |
$6.96 |
$66,830 |
D/D |
(9,602) |
62,183 |
|
- |
|
459 Records found
|
|
Page 7 of 19 |
|
|